The Developmental Processes in Schizophrenic Disorders project involves an ongoing series of longitudinal follow-through studies of individuals with a recent onset of schizophrenia. The proposed new protocol focuses particularly on developmental processes affecting work outcome in this initial period after onset of schizophrenia, drawing on findings that link cognitive deficits in schizophrenia to functional outcome. This initial period precedes any chronic disability patterns and is therefore of particular public health significance. The new protocol will determine the effects on work outcome of an intervention designed to enhance search for appropriate work or schooling and to increase ability to maintain work or school activities more successfully. The protocol will determine the predictors of level of work functioning attained in the context of the new work-focused intervention and maintenance on risperidone. Potential neurocognitive and environmental predictors of work and social functioning and clinical course will be examined. Aspects of early perceptual processing, allocation of attention, working memory, secondary verbal memory, and conceptual flexibility that are implicated as enduring vulnerability factors in schizophrenia and influences on functional outcome will be assessed, as will potential stresses and supportive influences in the environment. Schizophrenic patients from an earlier recent- onset cohort will be reassessed at an average of 8 years after their initial outpatient testing to examine the stability of hypothesized cognitive and psychophysiological vulnerability factors and their relationship to long-term outcome. Assessments of individuals focus on cognitive performance, Assessments of possible environmental factors examine stressful life events, social support, and use of coping strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH037705-15A1
Application #
2860858
Study Section
Clinical Psychopathology Review Committee (CPP)
Program Officer
Heinssen, Robert K
Project Start
1983-09-15
Project End
2004-01-31
Budget Start
1999-05-15
Budget End
2000-01-31
Support Year
15
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Other Domestic Higher Education
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Chen, Qiaolin; Sugar, Catherine A; Weiss, Robert E (2018) A Bayesian confirmatory factor model for multivariate observations in the form of two-way tables of data. Stat Med 37:1696-1710
Fernandez, Vindia G; Asarnow, Robert; Narr, Katherine L et al. (2018) Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia. Schizophr Res 199:221-225
Rosenfarb, Irwin Ford; Triana, Stephanie; Nuechterlein, Keith H et al. (2017) Expressed emotion and the escalation of depressive symptoms in individuals with recent-onset schizophrenia. Early Interv Psychiatry 11:351-353
McCleery, Amanda; Lee, Junghee; Fiske, Alan P et al. (2016) Longitudinal stability of social cognition in schizophrenia: A 5-year follow-up of social perception and emotion processing. Schizophr Res 176:467-472
Ventura, Joseph; Subotnik, Kenneth L; Ered, Arielle et al. (2016) Cognitive Assessment Interview (CAI): Validity as a co-primary measure of cognition across phases of schizophrenia. Schizophr Res 172:137-42
Nuechterlein, Keith H; Ventura, Joseph; McEwen, Sarah C et al. (2016) Enhancing Cognitive Training Through Aerobic Exercise After a First Schizophrenia Episode: Theoretical Conception and Pilot Study. Schizophr Bull 42 Suppl 1:S44-52
Ventura, J; Ered, A; Gretchen-Doorly, D et al. (2015) Theory of mind in the early course of schizophrenia: stability, symptom and neurocognitive correlates, and relationship with functioning. Psychol Med 45:2031-43
Pirnia, Tara; Woods, Roger P; Hamilton, Liberty S et al. (2015) Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability. Schizophr Res 161:357-66
Subotnik, Kenneth L; Casaus, Laurie R; Ventura, Joseph et al. (2015) Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial. JAMA Psychiatry 72:822-9
McCleery, A; Green, M F; Hellemann, G S et al. (2015) Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB). Psychol Med 45:2657-66

Showing the most recent 10 out of 135 publications